Featured Research

from universities, journals, and other organizations

Scientists At Princess Margaret Hospital And Amgen Discover Role Of T Cells In Bone Destruction

Date:
November 18, 1999
Source:
University Of Toronto
Summary:
The role of T cells in the crippling bone and cartilage deterioration characteristic of many diseases including arthritis and other inflammatory diseases has been unraveled for the first time by a research team at Princess Margaret Hospital and the AMGEN Research Institute. Inflammation can trigger the body's T cells to inadvertently cannibalize its own bone, leading to severe bone degeneration and debilitating pain.

Discovery may be the key to preventing joint destruction in arthritis

(Toronto, November 18, 1999) - The role of T cells in the crippling bone and cartilage deterioration characteristic of many diseases including arthritis and other inflammatory diseases has been unraveled for the first time by a research team at Princess Margaret Hospital and the AMGEN Research Institute. Inflammation can trigger the body's T cells to inadvertently cannibalize its own bone, leading to severe bone degeneration and debilitating pain.

The finding paves the way for future research into preventing the onset and progression of bone erosion in arthritis and the prevention of osteoporosis associated with many different kinds of diseases. The findings are reported in the November 18, 1999 issue of the journal Nature. The research was funded by the AMGEN Research Institute.

"Stunned" by Findings

The research marks the first time in the world that a research team has clearly identified the molecular cause of the bone and cartilage deterioration characteristic of many inflammatory diseases. Lead author Dr. Josef Penninger, an immunologist at Princess Margaret Hospital and the AMGEN Institute, and a member of the Departments of Medical Biophysics and Immunology at the University of Toronto said, "When I realized what we had found, I was stunned. This could be the seminal paper for the prevention and treatment of bone loss in arthritis, and perhaps even for the treatment of bone loss in leukemia, hepatitis, HIV/AIDS, diabetes, multiple sclerosis, lupus and other diseases associated with inflammation and bone loss." The research was a collaborative effort between Dr. Penninger and his colleague Dr. Young-Yun Kong in Toronto, and Drs. Ulrich Feige and Bill Boyle at AMGEN in Thousand Oaks, California.

Earlier this year, Drs. Penninger, Kong and Boyle discovered OPGL, a gene that triggers the body's cells to cannibalize its own bone, leading to severe osteoporosis. They also discovered that the same gene regulates the development of lymph nodes and white blood cells, the body's protection against infection. "We were puzzled by our finding that certain white blood cells, called T cells, produce a substance that triggers bone loss," said Dr. Penninger. "We set out to find out why T cells make OPGL. What we uncovered is a molecular trigger for bone destruction in many diseases such as arthritis and even cancer."

Cells Become Cannibals

The infantry of the body's immune system, T cells spend most of their lives waiting to fight off offending disease. When the body is attacked by a virus or bacteria, T cells are "turned on" and begin producing OPGL, causing local or systemic bone loss.

Diseases which cause inflammation, such as arthritis, hepatitis, AIDS and many others attract T cells, which arrive at the sight of the inflammation ready to fight. When they head into battle, T cells produce OPGL. "The production of OPGL probably allows our T cells to activate the development of other blood cells required to fight off infection," said Dr. Penninger. "Unfortunately in chronic viral infections, autoimmune diseases and some cancers, T cells do not stop their attack, causing the OPGL-producing T cells to seek out and destroy the body's own bone and cartilage."

"Many patients who suffer from chronic viral infections, infectious diseases, allergic conditions, autoimmune disorders or various forms of cancer experience mild or severe bone and cartilage loss," said Dr. Kong. "Until now, we never knew why or what the connection was. Now we know that diseases, which cause inflammation in the body and activate the immune system initiate a T cell attack, also triggering an attack against the bones. Now that we know what is causing that bone loss, we can stop it."

Arthritis Blocker Possible

On the heels of successful experiments in rats, a natural blocker of OPGL is currently in phase I human clinical trials in the United States. If the trials are successful, testing of the OPGL blocker may begin in patients with osteoporosis, metastatic bone disease or rheumatoid arthritis. In human studies, Dr. Penninger and his research team found that, without exception, 100 percent of all osteoarthritis and rheumatoid arthritis patients they examined expressed OPGL in their joints, making the correlation absolute. "Arthritis patients suffer from severe destruction of the bone surrounding their joints, causing irreversible damage to the joints, pain and permanent physical disabilities," said Dr Penninger. "When arthritic rats are injected with the OPGL inhibitor or blocker at the first sign of inflammation, bone loss and cartilage destruction stops completely. OPGL inhibition may also be the future treatment of choice to block the crippling bone loss associated with cancer or hepatitis."

Arthritis exists in over 100 forms and is responsible for disabling over 600,000 Canadians and affecting more than four million people, including men, women and children. The USA alone spends over $50 billion a year to treat arthritis and related diseases. Forms of arthritis include tendinitis, bursitis, fibromyalgia, lupus, rheumatoid and osteoarthritis. The common denominator of all forms of the disease is joint and musculoskeletal pain and bone loss and ultimately life-long crippling as a result of inflammation of the joint lining.

Princess Margaret Hospital, a teaching hospital of the University of Toronto, has achieved an international reputation as a global leader in the fight against cancer and is considered one of the top comprehensive cancer research and treatment centres in the world. PMH is a member of the University Health Network, which also includes Toronto General Hospital and Toronto Western Hospital. The AMGEN Research Institute is an integral part of AMGEN, the world's largest biotechnology company and an innovative and pioneering world-wide organization dedicated to the research and development, manufacture and marketing of human proteins for therapeutic use, using recombinant DNA technology.

-30-

For more information, contact:
Keri Schoonderwoerd
Communications Specialist
Princess Margaret Hospital
416-946-4501 ext.5771
(keri.schoonderwoerd@uhn.on.ca)


Story Source:

The above story is based on materials provided by University Of Toronto. Note: Materials may be edited for content and length.


Cite This Page:

University Of Toronto. "Scientists At Princess Margaret Hospital And Amgen Discover Role Of T Cells In Bone Destruction." ScienceDaily. ScienceDaily, 18 November 1999. <www.sciencedaily.com/releases/1999/11/991117110517.htm>.
University Of Toronto. (1999, November 18). Scientists At Princess Margaret Hospital And Amgen Discover Role Of T Cells In Bone Destruction. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/1999/11/991117110517.htm
University Of Toronto. "Scientists At Princess Margaret Hospital And Amgen Discover Role Of T Cells In Bone Destruction." ScienceDaily. www.sciencedaily.com/releases/1999/11/991117110517.htm (accessed July 28, 2014).

Share This




More Health & Medicine News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com
West Africa Gripped by Deadly Ebola Outbreak

West Africa Gripped by Deadly Ebola Outbreak

AFP (July 28, 2014) The worst-ever outbreak of the deadly Ebola epidemic grips west Africa, killing hundreds. Duration: 00:48 Video provided by AFP
Powered by NewsLook.com
Trees Could Save More Than 850 Lives Each Year

Trees Could Save More Than 850 Lives Each Year

Newsy (July 27, 2014) A national study conducted by the USDA Forest Service found that trees collectively save more than 850 lives on an annual basis. Video provided by Newsy
Powered by NewsLook.com
Google's Next Frontier: The Human Body

Google's Next Frontier: The Human Body

Newsy (July 27, 2014) Google is collecting genetic and molecular information to paint a picture of the perfectly healthy human. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins